Coronavirus (COVID-19) Information from the FAMHP: 27.06.2020 - Coronavirus and the fight led by the FAMHP: the FAMHP is preparing for a potential pandemic resurgence 26.06.2020 - Coronavirus and the fight led by the FAMHP: the FAMHP carries out hundreds of controls and inspections to ensure the compliance and safety of medicines and health products 25.06.2020 - Coronavirus and the fight led by the FAMHP: the FAMHP constantly monitors the safety of treatments 24.06.2020 - Coronavirus and the fight led by the FAMHP: solutions implemented by the FAMHP in the face of medical equipment shortages 23.06.2020 - Coronavirus and the fight led by the FAMHP: the FAMHP facilitates and supports the development of COVID-19 treatments and vaccines 22.06.2020 - Coronavirus and the fight led by the FAMHP: rigorous work to ensure each patient receives the treatment they need 19.06.2020 - Coronavirus : first COVID-19 vaccine trial authorized in Belgium 27.05.2020 - Coronavirus: hydroxychloroquine: off-label use strongly discouraged and new benefit-risk assessment for clinical trials 25.05.2020 - Coronavirus: reminder of the risks of chloroquine and hydroxychloroquine 11.05.2020 - Coronavirus: relaxation of paracetamol measures for pharmacists and patients 04.05.2020 - Coronavirus: European Medicines Agency recommends continued use of medicinal products for high blood pressure, heart and kidney disease 28.04.2020 - Coronavirus: extension of measures taken by FAMHP to avoid medicinal product shortages 24.04.2020 - Coronavirus: COVID-19 patients should also report adverse reactions 20.04.2020 - Coronavirus: delivery of medicinal products to ambulatory patients’ homes by the authorised hospital 17.04.2020 - Coronavirus: status of medicinal product stocks for hospitals 15.04.2020 - Coronavirus: the FAMHP continues to supply essential medicinal products for intensive care and provides hospitals with daily updates 14.04.2020 - Coronavirus: softening of measures concerning paracetamol 10.04.2020 - Coronavirus: measures taken by the FAMHP and relevant partners to continue to guarantee oxygen supplies 01.04.2020 - Coronavirus: FAMHP measures to avoid medication shortages 01.04.2020 - Coronavirus: hydroxychloroquine, chloroquine and Kaletra (lopinavir & ritonavir) are subject to controlled distribution in Belgium to enhance monitoring of treatments 25.03.2020 - Coronavirus: the FAMHP seizes postal packages containing counterfeit and other illegal medicinal products against COVID-19 24.03.2020 - Coronavirus: what medicinal products are used in the fight against COVID-19? 19.03.2020 - Coronavirus: do not pointlessly stock up on medicinal products 18.03.2020 - Coronavirus: the FAMHP is taking measures to guarantee continuity of treatment for patients suffering from chronic illnesses 16.03.2020 - Coronavirus: paracetamol remains the first choice for cases of fever and pain 16.03.2020 - Corona virus: first contact your general practitioner and/or pharmacist by phone if you suspect you have symptoms 04.03.2020 - Coronavirus: no shortage in medication supply, FAMHP closely monitoring the situation General information on www.info-coronavirus.be
